학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 512건 | 목록
1~20
Academic Journal
With, M. de; Knikman, J.; Man, F.M. de; Lunenburg, C.A.T.C.; Henricks, L.M.; Kuilenburg, A.B.P. van; Maring, J.G.; Staveren, M.C. van; Vries, N. de; Rosing, H.; Beijnen, J.H.; Pluim, D.; Modak, A.; Imholz, A.L.T.; Schaik, R.H.N. van; Schellens, J.H.M.; Gelderblom, H.; Cats, A.; Guchelaar, H.J.; Mathijssen, R.H.J.; Swen, J.J.; Meulendijks, D.
Clin Pharmacol Ther
Academic Journal
Wong, F.K.; Fruge, S.; Meulendijks, M.Z.; Christensen, J.M.; Iskhakov, D.; Ahn, L.; Valerio, I.L.; Eberlin, K.R.
Journal of Plastic, Reconstructive & Aesthetic Surgery. 83:276-281
Academic Journal
Monk, BJ; Smith, G; Lima, J; Long, GH; Alam, N; Nakamura, H; Meulendijks, D; Ghiorghiu, D; Banerjee, S
Gynecologic Oncology. 164:325-332
Academic Journal
Ernault, Auriane C., MSc; Verkerk, Arie O., PhD; Bayer, Jason D., PhD; Aras, Kedar, PhD; Montañés-Agudo, Pablo, MSc; Mohan, Rajiv A., PhD; Veldkamp, Marieke, PhD; Rivaud, Mathilde R., PhD; de Winter, Rosan, BSc; Kawasaki, Makiri, PhD; van Amersfoorth, Shirley C.M., MSc; Meulendijks, Eva R., MD MSc; Driessen, Antoine H.G., MD; Efimov, Igor R., PhD, FHRS; de Groot, Joris R., MD, PhD; Coronel, Ruben, MD, PhD
Heart Rhythm. 19(9):1461-1470
Academic Journal
Mechelen DV; Department of Electrical Engineering, Eindhoven University of Technology, 5600 MB Eindhoven, The Netherlands.; Meulendijks D; Department of Electrical Engineering, Eindhoven University of Technology, 5600 MB Eindhoven, The Netherlands.; Koumans M; Department of Electrical Engineering, Eindhoven University of Technology, 5600 MB Eindhoven, The Netherlands.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101204366 Publication Model: Electronic Cited Medium: Internet ISSN: 1424-8220 (Electronic) Linking ISSN: 14248220 NLM ISO Abbreviation: Sensors (Basel) Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Lanke S; Clinical and Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Waltham, Massachusetts, USA.; Miah K; Clinical and Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Waltham, Massachusetts, USA.; Olabode D; Clinical and Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Waltham, Massachusetts, USA.; Yang J; Clinical and Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Waltham, Massachusetts, USA.; Bachina S; Clinical and Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Waltham, Massachusetts, USA.; Ghiorghiu D; Late Clinical Development and Global Clinical Strategy, Oncology R&D, AstraZeneca, Baar, Switzerland.; Kirk G; Global Clinical Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Meulendijks D; Global Clinical Development, Oncology R&D, AstraZeneca, Barcelona, Spain.; Grinsted L; Late Oncology Statistics, Oncology R&D, AstraZeneca, Cambridge, UK.; de Giorgio-Miller V; Global Clinical Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Zhou D; Clinical and Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Waltham, Massachusetts, USA.; Gibbs M; Clinical and Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Waltham, Massachusetts, USA.; Vishwanathan K; Clinical and Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Waltham, Massachusetts, USA.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
Academic Journal
Liu JF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Colombo N; Gynecologic Oncology Program, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.; Oza AM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.; Frenel JS; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint Herblain, and Nantes Université, Nantes, France.; Corr BR; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado, Aurora, CO.; Rubinstein MM; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Nevadunsky NS; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology and Women's Health, Montefiore Medical Center, Bronx, NY.; Lheureux S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.; Gaba L; Department of Medical Oncology, IDIBAPS, Hospital Clínic, and Department of Medicine, University of Barcelona, Barcelona, Spain.; González Cortijo L; Department of Oncology, Hospital Universitario Quirónsalud, Madrid, Spain.; Salutari V; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.; You B; Department of Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), CITOHL, EPSILYON, Lyon, France.; Chiang S; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; O'Connor MJ; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Oplustil O'Connor L; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Meulendijks D; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Khatun M; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Ghiorghiu D; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Oaknin A; Medical Oncology Service, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Peeters SLJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.; Meulendijks D; Late Development Oncology, AstraZeneca, Cambridge, UK.; Kadric Z; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Ibrovic S; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Creemers GJ; Department of Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands.; Milosevic V; Department of Clinical Pharmacy, Elkerliek Hospital, Helmond, The Netherlands.; van de Poll M; Department of Clinical Pharmacy, Máxima Medical Centre, Eindhoven, The Netherlands.; Simkens LHJ; Department of Medical Oncology, Máxima Medical Centre, Eindhoven, The Netherlands.; Deiman BALM; Department of Molecular Biology, Catharina Hospital, Eindhoven, The Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.; Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.; Thijs AMJ; Department of Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Academic Journal
Jacobs, B.A.W.; Deenen, M.J.; Joerger, M.; Rosing, H.; Vries, N. de; Meulendijks, D.; Cats, A.; Beijnen, J.H.; Schellens, J.H.M.; Huitema, A.D.R.
CPT Pharmacometrics Syst Pharmacol
CPT: Pharmacometrics & Systems Pharmacology, Vol 8, Iss 12, Pp 940-950 (2019)
CPT: Pharmacometrics & Systems Pharmacology, Vol 8, Iss 12, Pp 940-950 (2019)
Academic Journal
Ernault, Auriane; Verkerk, Arie; Bayer, Jason D.; Aras, Kedar; Montañés-Agudo, Pablo; Mohan, Rajiv A.; Veldkamp, Marieke; Rivaud, Mathilde; Kawasaki, Makiri; van Amersfoorth, Shirley C.M.; Meulendijks, Eva R.; Driessen, Antoine H.G.; Efimov, Igor R.; de Groot, Joris R.; Coronel, Ruben
Journal of Molecular and Cellular Cardiology. 173:82-83
Academic Journal
Kondo S; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. Electronic address: shkondo@ncc.go.jp.; Katsuya Y; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.; Yonemori K; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.; Komuro K; Research and Development, AstraZeneca K.K., 3-1-1, Shibaura, Minato-ku, Tokyo, 108-0023, Japan.; Sugeno M; Research and Development, AstraZeneca K.K., 3-1, Ofuka-cho, Kita-ku, Osaka, 530-0011, Japan.; Kawata T; Research and Development, AstraZeneca K.K., 3-1, Ofuka-cho, Kita-ku, Osaka, 530-0011, Japan.; Ghiorghiu D; Late Development Oncology, AstraZeneca, City House, 132 Hills Road, Cambridge, CB2 1RY, UK.; Meulendijks D; Late Development Oncology, AstraZeneca, City House, 132 Hills Road, Cambridge, CB2 1RY, UK.; Yamamoto N; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Publisher: Elsevier Country of Publication: England NLM ID: 101694651 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-2942 (Electronic) Linking ISSN: 24682942 NLM ISO Abbreviation: Cancer Treat Res Commun Subsets: MEDLINE
Academic Journal
Henricks, L.M.; Merendonk, L.N. van; Meulendijks, D.; Deenen, M.J.; Beijnen, J.H.; Boer, A. de; Cats, A.; Schellens, J.H.M.
International Journal of Cancer. 144:2347-2354
Academic Journal
Henricks, L.M.; Lunenburg, C.A.T.C.; Man, F.M. de; Meulendijks, D.; Frederix, G.W.J.; Kienhuis, E.; Creemers, G.J.; Baars, A.; Dezentje, V.O.; Imholz, A.L.T.; Jeurissen, F.J.F.; Portielje, J.E.A.; Jansen, R.L.H.; Hamberg, P.; Tije, A.J. ten; Droogendijk, H.J.; Koopman, M.; Nieboer, P.; Poel, M.H.W. van de; Mandigers, C.M.P.W.; Rosing, H.; Beijnen, J.H.; Werkhoven, E. van; Kuilenburg, A.B.P. van; Schaik, R.H.N. van; Mathijssen, R.H.J.; Swen, J.J.; Gelderblom, H.; Cats, A.; Guchelaar, H.J.; Schellens, J.H.M.
European Journal of Cancer. 107:60-67
Academic Journal
Henricks, L.M.; Lunenburg, C.A.T.C.; Man, F.M. de; Meulendijks, D.; Frederix, G.W.J.; Kienhuis, E.; Creemers, G.J.; Baars, A.; Dezentje, V.O.; Imholz, A.L.T.; Jeurissen, F.J.F.; Portielje, J.E.A.; Jansen, R.L.H.; Hamberg, P.; Tije, A.J. ten; Droogendijk, H.J.; Koopman, M.; Nieboer, P.; Poel, M.H.W. van de; Mandigers, C.M.P.W.; Rosing, H.; Beijnen, J.H.; Werkhoven, E. van; Kuilenburg, A.B.P. van; Schaik, R.H.N. van; Mathijssen, R.H.J.; Swen, J.J.; Gelderblom, H.; Cats, A.; Guchelaar, H.J.; Schellens, J.H.M.
The Lancet Oncology. 19:1459-1467
Academic Journal
McManus, R. J.; Mant, J.; Meulendijks, C. F. M.; Salter, R. A.; Pattison, H. M.; Roalfe, A. K.; Hobbs, F. D. R.
BMJ: British Medical Journal, 2002 Feb . 324(7335), 459-464.
Academic Journal
The Pharmacogenomics Journal. October, 2017, Vol. 17 Issue 5, p441, 11 p.
Academic Journal
Knikman JE; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Lopez-Yurda M; Biometrics Department, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Meulendijks D; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Medical Oncology, Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Late Development Oncology, AstraZeneca, Cambridge, UK.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.; Schellens JHM; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Beijnen J; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Cats A; Division of Medical Oncology, Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.
Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Academic Journal
Volume 8: Turbomachinery, Parts A, B, and C. :2765-2774
Academic Journal
Tomasoa, N B, Meulendijks , D , Nijkamp, J, Cats, A & Dewit, L 2016, 'Clinical outcome in patients treated with simultaneous integrated boost-intensity modulated radiation therapy (SIB-IMRT) with and without concurrent chemotherapy for squamous cell carcinoma of the anal canal', Acta Oncologica, vol. 55, no. 6, pp. 760-766.
Academic Journal
Joerger, M.; Huitema, A. D R; Boot, H.; Cats, A.; Doodeman, V. D.; Smits, P. H. M.; Vainchtein, L.; Rosing, H.; Meijerman, I.; Zueger, M.; Meulendijks, D.; Cerny, T. D.; Beijnen, J. H.; Schellens, J. H M
Cancer Chemotherapy and Pharmacology. 75:763-772
검색 결과 제한하기
제한된 항목
[검색어] Meulendijks, D.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어